SEC Form 4 · accession 0000025445-18-000089

Crane NXT, Co. · CXT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP, CBS, People & Performance

Period of report

Feb 22, 2018

Accepted (ET)

Feb 26, 2018 · 4:59 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000025445

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
CRANE CO. COMMON, PAR VALUE $1.00	Feb 22, 2018	M	2,089	$64.78	A	16,997	D
CRANE CO. COMMON, PAR VALUE $1.00^F1,F2	Feb 22, 2018	S	2,089	$94.895	D	14,908	D
CRANE CO. COMMON, PAR VALUE $1.00	Feb 22, 2018	M	2,662	$58.47	A	17,570	D
CRANE CO. COMMON, PAR VALUE $1.00^F3,F2	Feb 22, 2018	S	2,662	$94.895	D	14,908	D
CRANE CO. COMMON, PAR VALUE $1.00	Feb 22, 2018	M	5,368	$43.57	A	20,276	D
CRANE CO. COMMON, PAR VALUE $1.00^F4,F2	Feb 22, 2018	S	5,368	$94.895	D	14,908	D
CRANE CO. COMMON, PAR VALUE $1.00	Feb 22, 2018	M	2,865	$73.90	A	17,773	D
CRANE CO. COMMON, PAR VALUE $1.00^F5,F2	Feb 22, 2018	S	2,865	$94.895	D	14,908	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F6	$64.78	Feb 22, 2018	M	2,089	D	—	Jan 27, 2024	CRANE CO. COMMON, PAR VALUE $1.00	2,089	0	D
Employee Stock Option (Right to Buy)^F7	$58.47	Feb 22, 2018	M	2,662	D	—	Jan 26, 2025	CRANE CO. COMMON, PAR VALUE $1.00	2,662	2,703	D
Employee Stock Option (Right to Buy)^F8	$43.57	Feb 22, 2018	M	5,368	D	—	Jan 25, 2026	CRANE CO. COMMON, PAR VALUE $1.00	5,368	10,736	D
Employee Stock Option (Right to Buy)^F9	$73.90	Feb 22, 2018	M	2,865	D	—	Jan 30, 2027	CRANE CO. COMMON, PAR VALUE $1.00	2,865	8,595	D

F1Concurrent sale of shares resulting from an exercise of options granted on 1/27/2014 and expiring on 1/27/2024.
F2Weighted average price at which shares were sold in multiple same-day transactions at prices ranging from $94.23 to $95.39. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Concurrent sale of shares resulting from an exercise of options granted on 1/26/2015 and expiring on 1/26/2025.
F4Concurrent sale of shares resulting from an exercise of options granted on 1/25/2016 and expiring on 1/25/2026.
F5Concurrent sale of shares resulting from an exercise of options granted on 1/30/2017 and expiring on 1/30/2027.
F6This option vested 25% on the first and 50% on the second, 75% on the third and 100% on the fourth anniversary of the date of grant (1/27/2014).
F7The remaining 25% will vest on the fourth anniversary of the grant date (01/26/2015).
F8This option vested 25% on the first and 50% on the second anniversary of the grant date (01/25/2016). The remaining 50% will vest on the third and fourth anniversary of the grant date.
F9This option vested 25% on the first anniversary of the grant date (01/30/2017). The remaining 75% will vest on the second, third and fourth anniversary of the grant date.